BDV
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
🇦🇺 ASX
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
📈 Performance
Price History
N/A
1M
All Time
Graph
Table
Performance graph isn't available yet for this share
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in BDV
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in BDV
N/A
BDV investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in BDV also invest in...
Want more shares? Try these...
BCAL Diagnostics Ltd. develops screening tests for the early detection of breast cancer. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-07-21. The Company’s core activity is the development of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer, which is available to all women. The company is developing diagnostic technology to assist in the early detection of breast cancer by identifying, measuring and validating specific biomarkers enriched in the patient’s blood. The company is engaged in the research and development of non-invasive diagnostic technologies designed to complement existing imaging technologies, such as the mammogram. Its BCAL laboratory employs liquid chromatography mass spectrometry (LCMS) platforms to build on the Company's clinical research and leverage progress. The Company’s BCAL test is a lipid biomarker blood (Breast Cancer Associated Lipids test) test with the potential to be used for breast cancer prevention, screening, and monitoring.
📊 Share price
$0.12 AUD
🧬 BIOTECHNOLOGY
BirdDog Technology Ltd. develops and manufactures audio-visual and video technology. The principal activities of the Company consist of development and manufacturing of global video technology that enhances the quality, speed and flexibility of video through a range of solutions, augmented with network device interface (NDI). These solutions are then sold through a network of distributors and resellers and direct, to individuals and organizations within professional video, corporate audio-visual (AV) and digital signage markets who demand broadcast quality video content. The Company’s product portfolio includes converters, camera lines, AV section, software, and accessories. The Company’s NDI Bridge transports complete NDI streams over local area network (LAN), wide area network (WAN) or public Internet. Its NDI Audio Direct makes audio-over-IP available for software-based audio applications.
📊 Share price
$0.04 AUD
🤖 TECHNOLOGY